Work

Continuous Subcutaneous Insulin Infusion (CSII) versus Multiple Daily Injections (MDI): Impact on Glycemic Control and Pregnancy Outcomes in Gestational Diabetes

Year: 2024

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Abstract: Objective: This study aims to compare the efficacy of two insulin administration methods — continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) — in managing glycemic levels and influencing pregnancy outcomes in gestational diabetes mellitus (GDM) patients. Methods: In total, 118 GDM patients admitted between January 2021 and May 2023 were randomly allocated into two groups using a computer-generated sequence. Patients in the MDI group received multiple daily injections, while those in the CSII group received continuous subcutaneous insulin infusion via an insulin pump. The study duration lasted from diagnosis until delivery. Glycemic control was measured by monitoring fasting blood glucose (FBG), postprandial blood glucose (PBG), and bedtime blood glucose (BBG) levels. Pregnancy outcomes included the incidence of hypoglycemia, premature rupture of membranes, postpartum hemorrhage, fetal distress, macrosomia, neonatal asphyxia, and preterm delivery. Results: Post-treatment, the CSII group showed better control of FBG, PBG, and BBG, which were significantly lower compared to the MDI group (p < 0.05). Furthermore, the incidence rates of complications such as hypoglycemia, fetal distress, neonatal asphyxia were significantly lower in the CSII group compared to the MDI group (p < 0.05). Conclusion: CSII offers better treatment outcomes for GDM patients compared to MDI. It effectively regulates blood glucose levels, optimizes pregnancy outcomes, and minimizes the risk of neonatal complications. Hence, CSII deserves further clinical endorsement and application. Clinical Trial Registration: The study has been registered on Chinese Clinical Trial Registration https://www.chictr.org.cn/ (registration number: ChiCTR2400088927).

Source: Clinical and Experimental Obstetrics & Gynecology

DOI: 10.31083/j.ceog5111238

Authors: Xiling Shi, Qinghua Cai, Siming Xin, Shan Wu, Yousu Shen

Institutions: Jiangxi Maternal and Child Health Hospital, Jiangxi Provincial People's Hospital, Nanchang Medical College

Language: English

Topic: Gestational Diabetes Research and Management

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,500